IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 68 filers reported holding IMMUNOCORE HLDGS PLC in Q2 2022. The put-call ratio across all filers is 1.69 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,633,528 | -13.4% | 89,278 | 0.0% | 0.50% | -11.3% |
| Q2 2023 | $5,353,109 | -14.2% | 89,278 | -32.0% | 0.56% | -17.7% |
| Q1 2023 | $6,238,806 | -27.1% | 131,288 | -12.5% | 0.68% | -23.3% |
| Q4 2022 | $8,560,500 | -0.1% | 150,000 | 0.0% | 0.89% | -0.4% |
| Q3 2022 | $8,571,000 | +64.1% | 150,000 | +7.1% | 0.90% | +51.3% |
| Q2 2022 | $5,223,000 | +2.5% | 140,000 | -17.9% | 0.59% | +17.9% |
| Q1 2022 | $5,097,000 | +66.1% | 170,472 | +89.4% | 0.50% | +146.6% |
| Q4 2021 | $3,069,000 | -8.0% | 90,000 | 0.0% | 0.20% | -12.8% |
| Q3 2021 | $3,336,000 | -5.1% | 90,000 | 0.0% | 0.23% | -2.1% |
| Q2 2021 | $3,515,000 | – | 90,000 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 576,923 | $24,560,000 | 4.02% |
| Rock Springs Capital Management LP | 2,292,285 | $97,583,000 | 2.13% |
| RTW INVESTMENTS, LP | 1,245,532 | $50,142,000 | 0.78% |
| Avidity Partners Management LP | 550,000 | $23,414,000 | 0.65% |
| Samsara BioCapital, LLC | 80,000 | $3,406,000 | 0.63% |
| Bain Capital Public Equity Management II, LLC | 300,871 | $12,808,000 | 0.53% |
| GENERAL ATLANTIC, L.P. | 950,000 | $40,442,000 | 0.47% |
| Baker Brothers Advisors | 2,520,730 | $107,307,000 | 0.46% |
| Perceptive Advisors | 400,000 | $17,028,000 | 0.22% |
| Pinz Capital Management, LP | 18,700 | $796,000 | 0.21% |